We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Scandinavian Researchers Discover Potential Arthritis Treatment

By LabMedica International staff writers
Posted on 06 Sep 2017
The natural polysaccharide alginate and particularly its sulfated derivatives have potent anti-oxidant, anti-inflammatory, and anti-immunogenic properties, which indicate that it may be a promising biomaterial to be explored for treatment of arthritis.

Degeneration of articular cartilage represents one of the most common causes of pain and disability in our aging society. More...
Current treatments only address the symptoms of joint disease, but not their underlying causes which include oxidative stress and inflammation in cartilage and surrounding tissues. Sulfated biopolymers that mimic aspects of the native extracellular environment of cartilage are recently gaining interest as a means to slow the inflammatory events responsible for tissue degeneration.

In searching for new approaches to treating arthritis, investigators at ETH Zurich (Switzerland), the Swiss Federal Laboratories for Materials Science and Technology (St. Gallen, Switzerland), and the Norwegian research institute SINTEF (Trondheim, Norway) worked with alginate, a long-chain polysaccharide isolated from the brown algae Laminaria hyperborea.

The investigators reported in the June 16, 2017, online edition of the journal Biomaterials Science that alginate - and particularly its sulfated derivatives - have potent anti-oxidant, anti-inflammatory, and anti-immunogenic properties in vitro. They found that these polymers exerted a free radical scavenging activity in a sulfation-dependent manner. In particular, the sulfation degree of substitution of alginate directly correlated with its ability to scavenge superoxide radicals and to chelate metal ions.

The investigators also studied the effect of sulfated alginate on the ability of IL-1beta (Interleukin 1beta) to stimulate inflammatory genes in human chondrocytes and found decreased expression of the pro-inflammatory markers IL-6 and CXCL8 (IL8), which inversely correlated with the sulfation degree. Moreover, in studies testing the ability of the alginates to modulate macrophage polarization, the investigators found that they decreased both the gene expression and synthesis of the proinflammatory cytokine TNF-alpha (Tumor necrosis factor-alpha) in human THP-1 macrophages with M1-like phenotype in a sulfation-dependent manner. Thus, sulfated alginates effectively protected against oxidative stress and inflammation in vitro and should be a promising biomaterial to be explored for treatment of osteoarthritis.

Related Links:
ETH Zurich
Swiss Federal Laboratories for Materials Science and Technology
SINTEF

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Electrolyte Analyzer
BKE-B
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New findings demonstrate that anti-Müllerian hormone (AMH) may help identify which breast cancer patients are most likely to benefit from chemotherapy plus endocrine therapy (Image Credit: Shutterstock)

AMH Test Helps Predict Adjuvant Chemotherapy Benefit in Premenopausal Breast Cancer

Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer can present a difficult treatment decision in premenopausal patients with low recurrence scores.... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth

Newborn screening in the United States relies on heel-stick blood spots to identify rare, treatable disorders through biochemical testing, but these programs generally do not assess inherited cancer risk... Read more

Microbiology

view channel
Image: The QIAstat-Dx BCID GPF Plus AMR Panel is the first QIAstat-Dx panel for bloodstream infections to receive FDA clearance (Photo courtesy of Qiagen)

FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection

Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting an estimated 1.7 million adults in the U.S. each year. Rapid identification of pathogens and antimicrobial... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.